Mimedx (MDXG) Total Debt (2011 - 2026)
Mimedx (MDXG) posted Total Debt of $17.2 million for Q2 2026, down 2.21% sequentially from $17.6 million in Q1 2026, and down 6.8% YoY from $18.5 million in Q2 2025.
Mimedx (MDXG) Total Debt (2011 - 2026) Analysis & Trends
Mimedx has reported Total Debt for 12 years, with the latest figure at $17.2 million in Q2 2026.
- Quarterly Total Debt fell 6.8% year-over-year to $17.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $17.2 million (down 6.8% YoY) and the FY2025 annual result came in at $18.0 million, down 4.58% from the prior year.
- Total Debt slipped to $17.2 million in Q2 2026 per MDXG's latest filing, from $17.6 million in the prior quarter.
- Over five years, Total Debt peaked at $49.1 million in Q4 2023 and troughed at $17.2 million in Q2 2026.
- A 5-year average of $32.1 million and a median of $20.7 million in 2024 frame the typical range for Total Debt.
- The sharpest annual moves came in 2023 and 2024: Total Debt advanced 1.04% in 2023, then plunged 61.65% in 2024.
- Over 5 years, Total Debt stood at $48.6 million in 2022, then advanced by 1.04% to $49.1 million in 2023, then sank by 61.65% to $18.8 million in 2024, then dropped by 4.58% to $18.0 million in 2025, then dropped by 4.24% to $17.2 million in 2026.
- According to Business Quant data, Total Debt over the past three periods registered $17.2 million, $17.6 million, and $18.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.07 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.34 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Mimedx | 622.24 Mn | 486.40 Mn | 44.38 Mn | 17.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.21 Mn |
| Mar 31, 2026 | 17.59 Mn |
| Dec 31, 2025 | 17.97 Mn |
| Sep 30, 2025 | 18.21 Mn |
| Jun 30, 2025 | 18.46 Mn |
| Mar 31, 2025 | 18.66 Mn |
| Dec 31, 2024 | 18.83 Mn |
| Sep 30, 2024 | 20.88 Mn |
| Jun 30, 2024 | 20.45 Mn |
| Mar 31, 2024 | 19.45 Mn |
| Dec 31, 2023 | 49.10 Mn |
| Sep 30, 2023 | 48.97 Mn |
| Jun 30, 2023 | 48.84 Mn |
| Mar 31, 2023 | 48.71 Mn |
| Dec 31, 2022 | 48.59 Mn |
| Sep 30, 2022 | 48.48 Mn |
| Jun 30, 2022 | 48.36 Mn |
| Mar 31, 2022 | 48.24 Mn |
| Dec 31, 2021 | 48.13 Mn |
| Sep 30, 2021 | 50.00 Mn |